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Abstract
Background: PhaR which is a repressor protein for microbial polyhydroxyalkanoates (PHA) biosynthesis, is able to 
attach to bacterial PHA granules in vivo, was developed as an affinity tag for in vitro protein purification. Fusion of PhaR-
tagged self-cleavable Ssp DnaB intein to the N-terminus of a target protein allowed protein purification with a pH and 
temperature shift. During the process, the target protein was released to the supernatant while PhaR-tagged intein was 
still immobilized on the PHA nanoparticles which were then separated by centrifugation.
Results: Fusion protein PhaR-intein-target protein was expressed in recombinant Escherichia coli. The cell lysates after 
sonication and centrifugation were collected and then incubated with PHA nanoparticles to allow sufficient 
absorption onto the PHA nanoparticles. After several washing processes, self-cleavage of intein was triggered by pH 
and temperature shift. As a result, the target protein was released from the particles and purified after centrifugation. 
As target proteins, enhanced green fluorescent protein (EGFP), maltose binding protein (MBP) and β-galactosidase 
(lacZ), were successfully purified using the PhaR based protein purification method.
Conclusion: The successful purification of EGFP, MBP and LacZ indicated the feasibility of this PhaR based in vitro 
purification system. Moreover, the elements used in this system can be easily obtained and prepared by users 
themselves, so they can set up a simple protein purification strategy by themselves according to the PhaR method, 
which provides another choice instead of expensive commercial protein purification systems.
Background
Fusion protein technology has been enthusiastically
developed since the advent of genetic engineering. It is a
c o n v e n i e n t  wa y  t o  s i m p l i fy  t h e  p u ri f i ca t i o n  s c h e m e  b y
adding a molecular handle to a recombinant protein [1,2].
A large amount of protein purification tags are available
now [3], such as polyhistidine (Poly-His), maltose-bind-
ing protein (MBP) and glutathione S-transferase (GST)
[4-6]. However, the cost of affinity resins and other
required reagents are the major obstacles that hinder
these tags to be developed into large-scale protein pro-
duction.
Polyhydroxyalkanoates (PHA) are a family of hydro-
phobic biopolyesters produced by many bacteria [7]. Sev-
eral types of proteins were found to attach on the surface
of in vivo PHA granules, such as PHA synthase (PhaC),
PHA depolymerase (PhaZ), granule associated protein
(PhaP) and repressor protein (PhaR) [8-11]. Some studies
showed that PhaR in the crude lysates of recombinant E.
coli was able to re bind to poly [(R)-3-hydroxybutyrate]
(PHB) granules [12-14]. PhaR has two separate domains,
including a DNA sequence binding domain and a PHB
granule binding domain [13]. Previous study proved that
PhaR was able to tightly attach to both artificial amor-
phous and crystalline PHB granules in vitro [13]. In addi-
tion, PhaR was reported to bind to the surface of
polyethylene, polystyrene and poly-lactic acid, which
shows the binding is non-specific, mainly by hydrophobic
interaction [14].
Intein-based controllable cleavages have been adopted
in increasing number of applications including the
IMPACT method for single-step purification of recombi-
nant proteins [15-17], the expressed protein ligation
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(EPL) method for protein ligation [18,19], and the cycl-
ization of recombinant proteins or peptides [20]. In a
more recent study [21], Ssp DnaB mini-intein was shown
as a promising tool for production of peptides of pharma-
ceutical interest [22].
Banki et al invented the intein-mediated protein purifi-
cation method using the in vivo PHB matrix association
phenomenon [8]. Since self-cleavage of intein is simply
induced by pH and temperature shift, it is becoming
important for various protein studies.
In our previous study, PhaP, the major binding protein
on in vivo PHA granules, was developed as an affinity tag
used for recombinant protein purification [23]. In this
paper, PhaR replaced PhaP for the purification system,
PhaR-intein tagged proteins expressed in recombinant E.
coli were released together with all other E. coli proteins
via a bacteria lysis process, they were bound to the sur-
face of PHA nanoparticles prepared in vitro. Similar to
the PhaP based system, PhaR based method was success-
fully used to purify green fluorescent protein (EGFP),
maltose-binding protein (MBP) and β-galactosidase
(LacZ) in vitro.
Materials and methods
Construction of plasmids
Plasmid pPIEGFP [23] available in our laboratory was
modified to generate corresponding proteins encoding
tripartite fusions of PhaR, Ssp DnaB mini-intein and tar-
get proteins. Primers R1 (5'-GGAAGATCTATGGCCA-
CGACCAA-3') and R2 (5'-CCCAAGCTTTTACTTCT
TGTCCG-3') were used to amplify phaR gene (GenBank:
NC 008313) from Ralstonia eutropha H16 genome. Then
HindIII and BglII digested phaR segment was inserted
into the corresponding site of IE segment amplified from
pPIEGFP to generate pRIEGFP using following primers:
IE1 (5'-CCCAAGCTTAACAACGGTAACAACGGTC
TC-3') and IE2 (5'-GGAAGATCTATGTATATCTCCT-
TCTTAAA-3'). To simplify plasmid constructions,
BamHI and XmaI sites were added to the terminals of RI
segment PCR amplified from pRIEGFP using primers RI1
(5'-CGCGGATCCGGCTGCTAACAAAG-3') and RI2
(5'-CCCCCCGGGGGAAGAGCCCTCGAGGAATT-3').
The lacZ gene encoding β-galactosidase was PCR ampli-
fied from E. coli S17-1 (ATCC 47055) genome employing
primers IZ1 (5'-CGCGGATCCTTATTTTTGACACCA-
GACCA-3') and IZ2 (5'-CCCCCCGGGACCATGATTAC
GGATTCACT-3'). Similarly, MBP gene was obtained
from pMAL-c2x (NEB) using primers M1 (5'-CGCG-
GATCCCAACATGAAAATCGAAGAAGGTAA
ACTGG-3') and M2 (5'-CCCCCCGGGTTATCGAGCT
CGAATTAGTCTGCG-3'). The BamHI and XmaI
digested MBP and lacZ  genes were then inserted into
corresponding sites of RI segment to generate plasmids
pRI-MBP and pRI-LacZ, respectively.
Protein expression and collection of crude cell lysates
Plasmids pRIEGFP, pRI-LacZ and pRI-MBP were trans-
formed into E. coli BL21 (DE3) for expression of PhaR-
intein tagged proteins, respectively. All recombinant
strains were cultivated in 1000 ml shake flasks containing
200 ml Luria Bertani medium (1% w/v Bacto tryptone,
0.5% yeast extract and 1% NaCl) supplemented with 100
μg ml-1 ampicillin in a rotary incubator at 200 rpm. E. coli
BL21 (DE3) transformants carrying corresponding plas-
mids were diluted 100: 1 from overnight cultures and
grown at 37°C. At OD600 = 0.5, 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG) was added to induce the
expression of fusion genes at 15°C overnight. Cells were
harvested by centrifugation at 11000 rpm for 2 min and
re-suspended in a binding buffer (20 ml 20 mM Tris-Cl
pH 8.5) followed by sonication (Ultrasonic crasher, Sci-
entz-II D, Ningbo, China) for 10 min at 50% output. After
centrifugation at 11000 rpm and 4°C for 30 min, the clari-
fied soluble protein fraction was collected and stored at -
20°C.
Preparation of PHA nanoparticles
PHA nanoparticles were prepared by the oil-in-water
emulsion method described previously [23]. In detail, 5%
w/v PHBHHx (copolymer of 88 mol% 3-hydroxybutyrate
and 12 mol% 3-hydroxyhexanoate, a member of PHA
polymer family) powders were dissolved in chloroform.
Subsequently, 10 mM sodium oleate aqueous solution
was added to the chloroform solution in a volume ratio of
1: 20. The mixed solution was emulsified by sonication
for a total 3 min at 50% output. The 3 minutes sonication
was carried out using a process of 1 second sonication
followed by 3 seconds pause to avoid overheating. The
chloroform was removed from the emulsion by a rotary
evaporator (RE-52AA, Shanghai, China) under vacuum
conditions. PHBHHx nanoparticles were harvested by
centrifugation at 11000 rpm for 10 min and washed twice
with an equal volume of distilled water. Then nanoparti-
cles were lyophilized for 24 h in a freeze dryer (Modu-
lyoD, Thermo, USA). The morphological analysis was
performed using scanning electron microscopy (SEM,
JSM-6360LA, Japan) and the approximate particle size
was evaluated (Fig. 1).
Self-cleavage of intein and the release of target proteins
The schematic illustration for nanoparticle based protein
purification is described below (Fig. 2): 4 ml Crude cell
lysates were incubated with 100 mg of PHBHHx nano-
particles in binding buffer (20 mM Tris-Cl, pH 8.5) at 4°C
overnight to allow sufficient attachment. PHBHHx nano-
particles coated with fusion proteins were collected by
centrifugation at 11000 rpm and 4°C for 10 min and
washed twice with 10 ml binding buffer, then re-sus-
pended in 1 ml cleavage buffer (20 mM Tris-Cl, pH 7.0) atZhang et al. Microbial Cell Factories 2010, 9:28
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25°C. In the cleavage process, a spot of pellets were taken,
washed and resolved by SDS-PAGE every other hour to
identify the completion of cleavage reaction. Finally, the
target proteins were completely released to supernatant,
and were separated with particles by centrifugation at
15000 rpm and 4°C for 5 min. Samples in each step were
collected, dissolved in SDS-PAGE sample loading buffer
(Beyotime, Jiangsu, China), followed by being boiled for 5
min. The supernatant was assayed by 12.5% SDS-PAGE
after centrifugation.
Assays of protein activities and yields
Protein concentration was measured as described in
Bradford's method [24] with a protein assay kit (Tiangen,
Beijing, China). The fluorescence intensity of purified
EGFP was visually inspected under a fluorescence micro-
scope. MBP was considered to be active if it can bind to
maltose resin. β-Galactosidase activity assay based on its
reaction with o-Nitrophenyl-β-D-galactopyranoside
(ONPG) was measured by β-galactosidase assay kit
(GMS60003.3, GENMED Scientifics Inc. USA). One unit
of β-galactosidase hydrolyzes 1.0 μmol ONPG to o-nitro-
phenol and D-galactose per minute at 37°C.
Results
Purification of three types of proteins and SDS-PAGE 
analysis
Three proteins were used to study the feasibility of the
PhaR based system, including enhanced green fluores-
cent protein (EGFP), maltose binding protein (MBP) and
β-galactosidase (LacZ) (Fig. 3). Three distinct bands of
fusion proteins PhaR-intein-EGFP (RI:EGFP) (Fig. 3A,
lane 2), PhaR-intein-MBP (RI:MBP) (Fig. 3B, lane 2) and
PhaR-intein-LacZ (RI:LacZ) (Fig. 3C, lane 2) in soluble
cell lysates were observed compared with pre-induced
whole cell lysate (Fig. 3, lane 1). After co-incubation of
soluble cell lysates and PHBHHx nanoparticles, proteins
attached on PHBHHx nanoparticles were shown in lane
3. The repeated washing process using washing buffer
excessively diluted the released proteins from the PHB-
HHx particles, this was the reason that no band was
observed in lanes 4 and 5, the small amount of the eluate
used for SDS-PAGE was also one of the reasons. After the
induced self-cleavage of intein, the PhaR-intein (RI) seg-
ment was still immobilized on the particle surface (Fig. 3,
lane 6), while the purified target proteins were released to
the supernatants (Fig. 3, lane 7).
Assays of purified protein activity
The purified EGFP emitted green fluorescence in natural
light, and the fluorescence became stronger when excited
Figure 1 SEM image of PHBHHx nanoparticles.
Figure 2 A schematic illustration for PhaR based protein purifica-
tion system. Fusion proteins of PhaR, intein and a target protein were 
expressed in E. coli BL21 (DE3), the cellular supernatant obtained after 
sonication and centrifugation contained all crude proteins that were 
subjected to incubation with PHBHHx nanoparticles. After the over-
night incubation at 4°C, the pellets were harvested and washed to re-
move unbound proteins. Subsequently, cleavage buffer was used to 
trigger self-cleavage of intein at 25°C. The target protein was released 
into the supernatant and separated from the pellets by centrifugation 
after cleavage incubation.Zhang et al. Microbial Cell Factories 2010, 9:28
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by light of 460-500 nm, which implied that EGFP was still
active after the PhaR based purification process. Activity
of the purified MBP was confirmed by its affinity to malt-
ose resin. After co-incubation of the purified MBP and
the maltose resin, no MBP was found in the supernatant
(Fig. 3B, lane 8). As shown in table 1, the activity of LacZ
in induced cells was greatly enhanced to 167 units com-
pared with only 7 units in pre-induced cells, indicating
the expression of active LacZ fusion. And the purified
LacZ had a much higher activity (487 units) than its
fusion (167 units) in cell lysate. The average yields based
on nanoparticle weight and wet bacterial weight were cal-
culated (Table 1). The efficiencies of the PhaR based sys-
tem was found to be similar to the PhaP based one
reported by our lab previously [23]. However, PhaR sys-
tem seemed to be more effective for protein purification
compared with that of the PhaP based in vivo system
developed by Banki et al [8]. For example, the PhaR sys-
tem developed in this study produced 4.01 mg MBP/g
wet weight of bacteria compared with only 1.34 mg from
Banki's system [8].
Discussion
In this study, a strong and controllable T7lac promoter
was employed to ensure high-level expression of three
fusion proteins, respectively. In order to avoid formation
of protein inclusion bodies, fusion protein expressions
were undertaken at temperature as low as 15°C. In addi-
tion, a flexible peptide linker was inserted between PhaR
and intein to ensure their correct folding. As a result, all
three soluble fusion proteins were successfully expressed
(Fig. 3, lane 2). However, undesired premature self-cleav-
age still occurred (Fig. 3, lane 2), the truncated PhaR-
intein segment would compete with intact tripartite
fusion for binding to nanoparticles. To tackle this prob-
lem, a sulfhydryl group induced intein was used to
replace pH and temperature induced intein. However, no
soluble fusion proteins were recovered (data not shown).
In addition to PhaR-intein segment, small amount of
cellular proteins could also bind to the PHA (PHBHHx)
nanoparticles even though PhaR tagged fusion protein
was the dominant protein on the nanoparticle surface
(Fig. 3, lane 3). The binding of other cellular proteins on
PHA nanoparticles reduced the loading capacity of target
proteins, leading to reduced efficiency of target protein
purification. Nevertheless, increased yield of target pro-
tein purification was still achieved compared with that of
the Banki's in vivo system. The separation of fusion pro-
tein production and PHA nanoparticle preparation
allows the use of large amount of PHA nanoparticles to
be attached by fusion proteins of PhaR-intein-target pro-
teins, thus could improve the recovered efficiency of the
target proteins. On one hand, both protein expression
and PHA nanoparticle preparation can be conveniently
achieved. In contrast, the in vivo PHA granule accumula-
tion is indeed a more complicated process, the extraction
of native PHA granules with target proteins attached on
their surface is time-consuming and laborious, resulting
in significant loss of target proteins. On the other hand,
PHA nanoparticles can be prepared in sufficient quantity
to allow all PhaR-intein-tagged proteins to absorb (Fig. 1).
Proteins purified by the in vitro method were reasonably
pure, no contaminant protein was found in purified pro-
tein solution (Fig. 3, lane 7). Only several steps of mild
washing and centrifugation processes were required
throughout this PhaR based purification course, other
treatment conditions were so mild that a high activity of
target protein can be maintained after the whole purifica-
tion process as demonstrated by the high LacZ activity
(Table 1) and binding ability of MBP (Fig. 3B, lane 8).
Figure 3 SDS-PAGE analysis of three protein samples subjected 
to the purification process. A: enhanced green fluorescent protein 
(EGFP); B: maltose binding protein (MBP) and C: β-galactosidase (LacZ). 
RI: PhaR-intein segment. Lane M, protein molecular weight standards; 
Lane 1: Pre-induced whole cell lysate; Lane 2: Soluble fractions (crude 
proteins) of induced cell lysate; Lane 3: Proteins absorbed on nanopar-
ticles; Lanes 4 and 5: First and second eluates; Lane 6: Pellets after self-
cleavage of intein; Lane 7: Supernatant after self-cleavage of intein; 
Lane 8: Supernatant after co-incubation with maltose resin.Zhang et al. Microbial Cell Factories 2010, 9:28
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Simultaneously, strong green fluorescence of purified
EGFP also indicated its activity.
The in vivo PHA matrix and PhaP based protein purifi-
cation system invented by Banki et al was cost-effective
and suitable for large-scale protein production [8]. The
method is more suitable for purifying prokaryotic pro-
teins as accumulation of PHA granules in eukaryotic
microorganisms are rare. This problem can be easily
addressed by separating protein expression and PHA
nanoparticle preparation processes, wherein PhaR tagged
proteins can be expressed freely in either prokaryotic or
eukaryotic organisms, allowing the PhaR based system
for the purification of eukaryotic proteins. This in vitro
method separating protein expression and PHA nanopar-
ticles preparation widens the applications of Banki's
method.
B e s i d e s  P H A ,  P h a R  c a n  a l s o  a t t a c h  t o  p o l y e t h y l e n e ,
polystyrene and poly(lactic acid) et al [14,23]. These
hydrophobic polymers can also be used to prepare nano-
particles to be used in the PhaR system. In this study we
c h o s e  P H B H H x  a s  a f f i n i t y  m a t r i x  o n l y  b e c a u s e  i t  w a s
available in large quantities in our laboratory. And it is
easier and much more cost-effective to prepare nanopar-
ticles than conventional chromatographic column. Sizes
and shapes of nanoparticles may not be important
although smaller size will give larger surface area. Impor-
tantly, the nanoparticles used in this purification system
can be easily prepared by all users themselves. Ideally,
researchers can set up a simple protein purification strat-
egy by themselves according to the PhaR method, it is not
necessary to buy an expensive protein purification sys-
tem, when they just need small amount of pure proteins.
Certainly, the amount of purified protein depends on how
many nanoparticles are used.
Intein mediated self-cleavage system has been devel-
oped as a powerful tool for protein purification, protein
ligation, and peptide amidation [16,19,25-27]. The intein-
based methods sometimes involve minimal risk of non-
specific cleavage at unintended locations within the tar-
get proteins, yet intein is still effective compared with
some protease-based methods [28-31]. Completely con-
trollable cleavage of intein and target proteins is still a
challenge, in which the cleavage reaction is induced only
when needed, i.e., after the intein-target protein complex
has been expressed and purified successfully.
The data presented here have proven the feasibility of
this PhaR based protein purification system. However,
some short-comings still need to be improved. Firstly,
some nanoparticles often aggregated during the centrifu-
gation processes, it was difficult to re-suspend them, this
reduced the final yield of target protein. Secondly, the
complete cleavage of intein took as long as 24 h, which
may result in reduction of target protein activity. An
intein cleavage with a short cleavage time is desirable.
Conclusions
The in vitro purification system based on intein and PhaR
as the affinity tag able to attach to the surface of PHA
nanoparticles (in this case, PHBHHx) was used success-
fully for purifying three proteins including EGFP, MBP
and LacZ. Comparable to several other PHA bind pro-
teins including PhaP, PhaZ and possibly PhaC, PhaR, as
a n  a f f i n i t y  t a g ,  i s  a t  l e a s t  a s  g o o d  a s  o t h e r s  f o r  p u r e
recombinant protein production. Moreover, PhaR (20
kDa) is smaller than PhaP (21 kDa), PhaZ (45 kDa) and
PhaC (65 kDa) in Ralstonia eutropha H16, therefore, its
expression and accumulation should be more effective
and richer compared with others.
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Table 1: Effect of PhaR based protein purification method for purifying EGFP, MBP and LacZ, respectively
Yield of purified protein LacZ activity (Units/mg a)
Target proteins mg/g nanoparticles mg/g wet weight of 
bacteria
Pre-induced whole 
cell lysate
Induced whole cell lysate Purified LacZ
EGFP 9.14 ± 1.2 4.39 ± 0.5
MBP 8.17 ± 1.06 4.01 ± 0.3
LacZ 6.55 ± 0.9 3.16 ± 0.3 7.22 ± 0.9 167 ± 7.5 486.77 ± 15
a One unit of β-galactosidase activity hydrolyzes 1.0 μmol ONPG to o-nitrophenol and D-galactose per minute at 37°C.Zhang et al. Microbial Cell Factories 2010, 9:28
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